0001104659-18-055820.txt : 20180907 0001104659-18-055820.hdr.sgml : 20180907 20180907170036 ACCESSION NUMBER: 0001104659-18-055820 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180823 FILED AS OF DATE: 20180907 DATE AS OF CHANGE: 20180907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fricker William CENTRAL INDEX KEY: 0001752213 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 181060700 MAIL ADDRESS: STREET 1: 300 THE AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 3 1 a3.xml 3 X0206 3 2018-08-23 0 0000722830 IMMUNOMEDICS INC IMMU 0001752213 Fricker William C/O IMMUNOMEDICS 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 0 1 0 0 See Remarks Stock Options (right to buy) 16.66 2019-02-01 2025-02-01 Common stock, $0.01 par value per share 15000 D The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 25% on a annual basis thereafter. On August 23, 2018, the Company appointed Mr. William Fricker, the Company's Executive Director and Corporate Controller, to serve as the Company's principal accounting officer. /s/ William Fricker 2018-09-07